Informacje o tej pozycji
biological source
mouse
Quality Segment
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
10F6, monoclonal
species reactivity
mouse, human, rat
manufacturer/tradename
Chemicon®
technique(s)
immunohistochemistry: suitable, western blot: suitable
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
General description
Immunogen
Application
Neuroscience
Neurodegenerative Diseases
Neuronal & Glial Markers
Biochem/physiol Actions
Physical form
Preparation Note
Analysis Note
rat brain tissue lysate
Other Notes
Legal Information
Disclaimer
1 of 1
Ta pozycja | |||
|---|---|---|---|
| description clone 10F6, Chemicon®, from mouse | description clone 7A8, ascites fluid | description Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab1 | description - |
| clone 10F6, monoclonal | clone 7A8, monoclonal | clone polyclonal | clone 9O0B3, monoclonal |
| biological source mouse | biological source mouse | biological source rabbit | biological source rabbit |
| species reactivity mouse, human, rat | species reactivity marsupial (Ptoorous tridactylis PtK2 cell line), rat | species reactivity human | species reactivity rat, human |
| Gene Information human ... ACTC1(70), ACTG1(71) | Gene Information rat ... Plec1(64204) | Gene Information human ... PLEC1(5339) | Gene Information human ... PLEC(5339) |
| antibody form purified antibody | antibody form ascites fluid | antibody form affinity isolated antibody | antibody form - |
| conjugate unconjugated | conjugate unconjugated | conjugate unconjugated | conjugate unconjugated |
Still not finding the right product?
Wypróbuj nasze narzędzie Narzędzie selektora produktów, aby zawęzić opcje.
Klasa składowania
12 - Non Combustible Liquids
Co się dzieje?
WGK 2
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.



